NM_021619.3:c.1068_1076delCGCCGCCGC

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_021619.3(PRDM12):​c.1068_1076delCGCCGCCGC​(p.Ala357_Ala359del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0628 in 955,184 control chromosomes in the GnomAD database, including 1,801 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 211 hom., cov: 0)
Exomes 𝑓: 0.065 ( 1590 hom. )

Consequence

PRDM12
NM_021619.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.33
Variant links:
Genes affected
PRDM12 (HGNC:13997): (PR/SET domain 12) This gene encodes a transcriptional regulator of sensory neuronal specification that plays a critical role in pain perception. The encoded protein contains an N-terminal PRDI-BF1 and RIZ homology (PR) domain, a SET domain, and three C-terminal C2H2 zinc finger DNA-binding domains. Naturally occurring mutations in this gene are associated with congenital insensitivity to pain (CIP), and hereditary sensory and autonomic neuropathies (HSAN's) affecting peripheral sensory and autonomic neurons. Deregulation of this gene is associated with solid cancers and hematological malignancies including chronic myeloid leukaemia. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_021619.3
BP6
Variant 9-130681605-TCGCCGCCGC-T is Benign according to our data. Variant chr9-130681605-TCGCCGCCGC-T is described in ClinVar as [Benign]. Clinvar id is 475809.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-130681605-TCGCCGCCGC-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0622 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRDM12NM_021619.3 linkc.1068_1076delCGCCGCCGC p.Ala357_Ala359del disruptive_inframe_deletion Exon 5 of 5 ENST00000253008.3 NP_067632.2 Q9H4Q4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRDM12ENST00000253008.3 linkc.1068_1076delCGCCGCCGC p.Ala357_Ala359del disruptive_inframe_deletion Exon 5 of 5 1 NM_021619.3 ENSP00000253008.2 Q9H4Q4
PRDM12ENST00000676323.1 linkc.906+162_906+170delCGCCGCCGC intron_variant Intron 5 of 5 ENSP00000502471.1 A0A6Q8PH01

Frequencies

GnomAD3 genomes
AF:
0.0482
AC:
6836
AN:
141844
Hom.:
211
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0258
Gnomad AMI
AF:
0.00457
Gnomad AMR
AF:
0.0533
Gnomad ASJ
AF:
0.0918
Gnomad EAS
AF:
0.00746
Gnomad SAS
AF:
0.0162
Gnomad FIN
AF:
0.0488
Gnomad MID
AF:
0.0377
Gnomad NFE
AF:
0.0638
Gnomad OTH
AF:
0.0595
GnomAD3 exomes
AF:
0.0625
AC:
1
AN:
16
Hom.:
0
AF XY:
0.125
AC XY:
1
AN XY:
8
show subpopulations
Gnomad NFE exome
AF:
0.0625
GnomAD4 exome
AF:
0.0654
AC:
53193
AN:
813300
Hom.:
1590
AF XY:
0.0652
AC XY:
24605
AN XY:
377240
show subpopulations
Gnomad4 AFR exome
AF:
0.0263
Gnomad4 AMR exome
AF:
0.0306
Gnomad4 ASJ exome
AF:
0.100
Gnomad4 EAS exome
AF:
0.00531
Gnomad4 SAS exome
AF:
0.0170
Gnomad4 FIN exome
AF:
0.0119
Gnomad4 NFE exome
AF:
0.0679
Gnomad4 OTH exome
AF:
0.0552
GnomAD4 genome
AF:
0.0482
AC:
6836
AN:
141884
Hom.:
211
Cov.:
0
AF XY:
0.0460
AC XY:
3164
AN XY:
68736
show subpopulations
Gnomad4 AFR
AF:
0.0259
Gnomad4 AMR
AF:
0.0532
Gnomad4 ASJ
AF:
0.0918
Gnomad4 EAS
AF:
0.00748
Gnomad4 SAS
AF:
0.0161
Gnomad4 FIN
AF:
0.0488
Gnomad4 NFE
AF:
0.0638
Gnomad4 OTH
AF:
0.0591

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Congenital insensitivity to pain-hypohidrosis syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Jul 23, 2019
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Aug 18, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752427775; hg19: chr9-133556992; API